BBJ Report: Questions Linger After Shire-Dyax Deal

The deal was finalized last week

The Shire Pharmaceuticals Company is not saying whether the company plans to keep the Burlington facility owned by the newly-acquired Dyax Corporation.

Guest Jessica Bartlett of the Boston Business Journal discusses the lingering questions about the Shire-Dyax deal.

Read the full report here.

Contact Us